Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1650 of 6351
-
Can a smartphone app and a coach help young sickle cell patients hurt less?
Symptom relief Recruiting nowThe study, known as the Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE), aims to determine the effectiveness of digital CBT in reducing pain, opioid use, and healthcare utilization among AYAs …
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Could a simple education program boost colorectal cancer screening and save lives?
Prevention CompletedThis randomized controlled trial evaluated the effect of a Health Belief Model-based multicomponent education program on colorectal cancer screening completion, knowledge, health beliefs, and screening attitudes among adults aged 50-70 years. A total of 176 participants were rand…
Sponsor: Bartın Unıversity • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Talking therapies take on migraine pain
Symptom relief Completedhis randomized controlled trial aims to evaluate the efficacy of Cognitive Behavioral Therapy (CBT) and Traditional Integrated Islamic Psychotherapy (TIIP) as psychological interventions for individuals with chronic migraine. The study will compare the effects of CBT and TIIP wit…
Sponsor: GIFT University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New toolkit aims to stop mental health problems before they start in military airmen
Prevention Recruiting nowSub-clinical behavioral health services in the military are performed by BH technicians, who receive minimal training. Due to this, embedding more technicians in military units is unlikely to benefit service members. Giving technicians training in, and access to, evidence-based i…
Sponsor: New York University • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
A new care protocol aims to support pregnant women in disaster zones
Symptom relief CompletedIt was designed as a randomized controlled experimental study to determine whether the care protocol planned for pregnant women in the disaster area positively affects their physical and psychological health.
Sponsor: Sakarya University • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Steroids may ease painful skin side effect of breast cancer chemo
Symptom relief Recruiting nowInvestigating the Association Between Corticosteroid Use and Improvement in Doxorubicin Liposome-Induced Cutaneous Toxicity: Exploring the Feasibility and Mechanisms of Corticosteroids in Mitigating Liposomal Doxorubicin-Related Dermatologic Adverse Effects.
Phase 3 • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Light-Based device could predict chemo success in breast cancer
Diagnosis Recruiting nowThe purpose of this study is to assess the feasibility of the NearWave optical molecular monitoring system for monitoring therapy progression and predicting pathologic complete response (pCR) of breast cancer patients undergoing neoadjuvant chemotherapy (NAC).
Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
New hope for kidney transplant patients facing rejection
Disease control OngoingThe primary objective of this study is to evaluate the efficacy of ALXN2030 compared with placebo on biopsy proven histologic resolution in participants with active or chronic active antibody-mediated rejection (AMR) at Week 52.
Phase 2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
AI therapist in virtual reality aims to treat depression
Symptom relief Recruiting nowDepression is a prevalent mental disorder characterized by pervasive low mood, diminished interest or pleasure, and a range of cognitive and physical symptoms. According to the World Health Organization (WHO), depression is a leading cause of disability worldwide, affecting appro…
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 26, 2026 17:07 UTC
-
New weight loss pill shows promise in early trial
Disease control CompletedThis is a Phase 2a multicenter, randomized, double-blind, placebo-controlled clinical trial studying the efficacy, safety, and tolerability of orally administered TERN-601 in adults with overweight or obesity.
Phase 2 • Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
One shot of methadone during surgery could slash opioid prescriptions
Symptom relief Recruiting nowCurrently, there is a nationwide epidemic of opioid abuse and overdose deaths. One source of excess opioids is overprescribing in the postoperative period. This study aims to find the optimal pain medication plan during and after laparoscopic hysterectomy to eliminate long-term o…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New ultrasound technique could spot breast cancer without a needle
Diagnosis Recruiting nowPurpose: This study will evaluate how measurements of tissue stiffness, viscosity, and anisotropy using non-invasive ultrasound imaging correlate with breast tumor malignancy and response to chemotherapy. Participants: Up to 200 women with benign or malignant breast tumors for a…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Could a common diabetes drug unlock the mystery of insulin failure?
Knowledge-focused Recruiting nowInsulin is a hormone that is made by β-cells in the pancreas and when released into the bloodstream helps control blood sugar levels. Insulin release is regulated by electrical activity in the β-cell which is generated by the ATP-sensitive potassium (KATP) channel. While reduced …
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Bacteria injected into tumors: a new hope for cancer patients?
Disease control Recruiting nowThis is a prospective, open-label, single-arm exploratory clinical trial to evaluate the safety and efficacy of CMTS1215 (Proteus mirabilis) oncolytic bacteria injection for the treatment of solid tumors. The study aims to enroll at least 8 patients with histologically confirmed …
Phase 1/2 • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo aims to protect kidney transplants from early failure
Disease control OngoingProspective double blind randomized controlled trial. By randomizing patients undergoing kidney transplantation into a conventional catecholamine drug (dobutamine) blood pressure maintenance group and a terlipressin-complexed dobutamine group, the investigators compared the effec…
Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New belly pain test could save kids from unnecessary hospital trips
Diagnosis Recruiting nowBACKGROUND Acute appendicitis (AA) in an early stage is difficult to distinguish from other (self-limiting) causes of acute abdominal pain (e.g. constipation and gastroenteritis), resulting in missing 19% of children with AA at first presentation in primary care and 70% of non-AA…
Sponsor: University Medical Center Groningen • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Fat-Derived stem cells injected into spine to fight progressive MS
Disease control Recruiting nowIn this study, we propose, for the first time, to test the safety and the potential efficacy of repeated allogenic Adipose tissue-derived Mesenchymal Stromal Cells IT injections in Primary Progressive Multiple Sclerosis patients.
Phase 1 • Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Steroid shot could ease knee pain without surgery
Symptom relief Recruiting nowThe value of corticosteroid infiltration of the meniscus wall in the therapeutic strategy is not clearly defined: the data in the literature on the effectiveness of corticosteroid infiltration are heterogeneous and of low level of proof. We hypothesize that corticosteroid infiltr…
Phase 3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Heart failure recovery: time to cut the pills?
Disease control Recruiting nowStudy start date is on Nov 27th 2024. A patient with an initial ejection fraction (EF) of less than 40%, whose follow-up shows an improvement to an EF of 50% or higher, along with the left ventricular end-diastolic diameter returning to the normal range and taking 3 more heart f…
Sponsor: Chungnam National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for rare cancers: first human trial of ANS03 begins
Disease control Recruiting nowThis is a first-in-human Phase I, multi-center, open-label study of ANS03 in patients with advanced solid tumors. The study evaluates the safety, tolerability, preliminary efficay, pharmacokinetics, anti-tumor activity of ANS03 as monotherapy.
Phase 1 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC